Medlive Technology Co Ltd

2192•Hong Kong Stock Exchange

Healthcare Hong Kong Health Information Services

Need professional-grade analysis? Visit stockanalysis.com

HK$8.94

-2.72%

End of day

Market Cap

$6.52B

P/E Ratio

16.94

Employees

724

Dividend Yield

3.02%

Price Chart

Risk-Adjusted Performance

Ratio	1W	1M	3M	6M	1Y	5Y	Score
Sortino	-1.47	15.71	-1.89	-1.22	-0.79	—	1.03
Calmar	-11.83	70.57	-1.80	-0.92	-0.48	—	7.86
Sharpe	-0.93	7.92	-1.55	-0.83	-0.53	—	0.29
Omega	0.74	2.02	0.64	0.86	0.94	—	0.99
Martin	-23.44	—	-2.72	-1.66	-0.85	—	-3.27
Ulcer	1.59	2.29	24.49	24.55	30.89	—	22.15

Medlive Technology Co Ltd (2192) Price Performance

Medlive Technology Co Ltd (2192) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Health Information Services industry. The stock currently trades at HKD8.94, down 2.72% from the previous close.

Over the past year, 2192 has traded between a low of HKD7.66 and a high of HKD16.88. The stock has lost 24.0% over this period. It is currently 47.0% below its 52-week high.

Medlive Technology Co Ltd has a market capitalization of $6.52B, with a price-to-earnings ratio of 16.94 and a dividend yield of 3.02%.

About Medlive Technology Co Ltd

Medlive Technology Co., Ltd. operates an online professional physician platform in Mainland China and internationally. The company's precision marketing and corporate solution provides digital marketing, digital detailing, digital marketing consultation, digital content creation, application software development, and other relevant services. Its medical knowledge solution offers medical education and clinical decision support, including licensing software to physicians and other registered users, such as other healthcare professionals and pharmaceutical companies. The company's intelligent patient management solutions include single disease management services, such as disease knowledge dissemination and treatment compliance monitoring; patient education services comprising content development, application software development, and other related services; and chronic disease management services for Parkinson's lymphoma, stroke and diabetes, breast cancer, lung cancer, and ovarian cancer. In addition, it is involved in the provision of research and development services; provision of internet hospital services; provision of publication and planning services for medicine guidelines and medical consensus; organizing medical exhibition conferences; provision of medical services; and provision of research services to pharmaceutical companies. The company was formerly known as Kingyee Co., Limited and changed its name to Medlive Technology Co., Ltd. in 2021. The company was founded in 1996 and is headquartered in Beijing, China.

Company Info

Sector: Healthcare
Industry: Health Information Services
Exchange: Hong Kong Stock Exchange
Currency: HKD
Country: Hong Kong

Financial Metrics

Revenue (TTM): $642.16M
EBITDA: $170.58M
Profit Margin: 52.06%
EPS (TTM): 0.44
Book Value: 7.57

Technical Indicators

52 Week High: HK$17.02
52 Week Low: HK$7.51
50 Day MA: HK$9.04
200 Day MA: HK$11.47
Beta: 0.45

Valuation

Trailing P/E: 16.94
Forward P/E: 17.45
Price/Sales: 10.15
Price/Book: 1.14
Enterprise Value: $2.12B